Transchem share news, announcements and annual reports
BSE: 500422Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹407.60.
30 Oct: open ₹418.00, high ₹418.00, low ₹400.00
- Next results date: the board meets on 4 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹499 Cr2,295th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 74.17
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −4.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 10,554
Transchem share news and announcements
591 announcements, routine notices left out, newest first. Page 3 of 12.
Jul 2024
12 Jul · Board meeting
Meeting on 20 Jul 2024: quarterly results
May 2024
9 May · Board meeting
Meeting on 18 May 2024: audited results and quarterly results
Apr 2024
22 Apr · Legal
Exchange has sought clarification from Transchem Ltd on April 22, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....17 Apr · Certificate Under Regulation 40(9) Of The SEBI Listing Regulations
17 Apr · Compliance Certificate Under Regulation 7(3) For The Year Ended March 31, 2024
17 Apr · Company Is Not A Large Entity
Jan 2024
17 Jan · Board meeting
Meeting on 25 Jan 2024: quarterly results
Dec 2023
Nov 2023
Oct 2023
27 Oct · Board meeting
Meeting on 4 Nov 2023: quarterly results
Aug 2023
Jul 2023
28 Jul · Board meeting
Meeting on 5 Aug 2023: quarterly results
Jun 2023
20 Jun · Disclosure
May 2023
Apr 2023
28 Apr · Board meeting
Meeting on 6 May 2023: quarterly results12 Apr · Compliance Certificate For The Year Ended March 31, 2023
12 Apr · Disclosure That The Company Is Not A Large Entity
12 Apr · Submission Of Certificate Pursuant To Regulation 40(9) And (10) Of SEBI Listing Regulations
Feb 2023
Jan 2023
24 Jan · Board meeting
Meeting on 4 Feb 2023: quarterly results
Dec 2022
Nov 2022
4 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
17 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 013 Oct · Submission Under Regulation 7(4) Of The SEBI Listing Regulation
Sep 2022